Cargando…
A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice
Human metapneumovirus (HMPV) and human respiratory virus (HRSV) are two leading causes of acute respiratory tract infection in young children. While there is no licensed drug against HMPV, the monoclonal antibody (mAb) Palivizumab is approved against HRSV for prophylaxis use only. Novel therapeutics...
Autores principales: | Fausther-Bovendo, Hugues, Hamelin, Marie-Eve, Carbonneau, Julie, Venable, Marie-Christine, Checkmahomed, Liva, Lavoie, Pierre-Olivier, Ouellet, Marie-Ève, Boivin, Guy, D’Aoust, Marc-André, Kobinger, Gary P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599547/ https://www.ncbi.nlm.nih.gov/pubmed/36289776 http://dx.doi.org/10.3390/biomedicines10102516 |
Ejemplares similares
-
Effects of Different Drug Combinations in Immunodeficient Mice Infected with an Influenza A/H3N2 Virus
por: Mhamdi, Zeineb, et al.
Publicado: (2020) -
Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development
por: Dubois, Julia, et al.
Publicado: (2019) -
Design and Validation with Influenza A Virus of an Aerosol Transmission Chamber for Ferrets
por: Turgeon, Nathalie, et al.
Publicado: (2019) -
In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors
por: Fage, Clément, et al.
Publicado: (2018) -
Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
por: Andrade, Catalina A., et al.
Publicado: (2020)